Program Schedule

577
Drugs in the Pipeline

Session: Symposium: HIV State-of-the-Art
Friday, October 10, 2014: 8:30 AM
Room: The Pennsylvania Convention Center: 103-ABC
Paul Sax, MD, FIDSA, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), Boston. He has been on the faculty at Harvard Medical School since 1992, where he is Professor of Medicine. Dr. Sax received his MD from Harvard Medical School in 1987. He served his residency in Internal Medicine at BWH, while continuing his postdoctoral education with a fellowship in the Infectious Disease Unit of Massachusetts General Hospital. Dr. Sax is board certified in Internal Medicine and Infectious Diseases. He is Editor-in-Chief of AIDS Clinical Care, is on the Peer Review board of the HIV/AIDS Section of UpToDate, and the editorial board of Medscape HIV/AIDS. Dr. Sax is also on the core faculty of the International AIDS Society - USA and the New England AIDS Education and Training Center. In addition to his clinical and teaching work, Dr. Sax is actively involved in HIV research. Ongoing areas of research interest include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group.



See more of: HIV State-of-the-Art
See more of: Symposium
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek